Elkhorn Partners’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.3K | Sell |
14,500
-24,424
| -63% | -$99.9K | 0.04% | 30 |
|
|
2025
Q1 | $67K | Sell |
38,924
-2,505
| -6% | -$4.31K | 0.04% | 28 |
|
|
2024
Q4 | $61K | Buy |
41,429
+4,988
| +14% | +$7.34K | 0.04% | 32 |
|
|
2024
Q3 | $62K | Buy |
36,441
+441
| +1% | +$750 | 0.04% | 37 |
|
|
2024
Q2 | $76K | Hold |
36,000
| – | – | 0.05% | 31 |
|
|
2024
Q1 | $79K | Buy |
36,000
+4,100
| +13% | +$9K | 0.06% | 31 |
|
|
2023
Q4 | $110K | Sell |
31,900
-13,441
| -30% | -$46.3K | 0.08% | 25 |
|
|
2023
Q3 | $67K | Hold |
45,341
| – | – | 0.04% | 37 |
|
|
2023
Q2 | $70K | Sell |
45,341
-5,000
| -10% | -$7.72K | 0.04% | 36 |
|
|
2023
Q1 | $54K | Hold |
50,341
| – | – | 0.04% | 34 |
|
|
2022
Q4 | $58K | Hold |
50,341
| – | – | 0.04% | 28 |
|
|
2022
Q3 | $46K | Buy |
50,341
+16,341
| +48% | +$14.9K | 0.03% | 33 |
|
|
2022
Q2 | $52K | Buy |
34,000
+10,288
| +43% | +$15.7K | 0.03% | 35 |
|
|
2022
Q1 | $104K | Buy |
23,712
+8,512
| +56% | +$37.3K | 0.06% | 28 |
|
|
2021
Q4 | $90K | Buy |
15,200
+6,700
| +79% | +$39.7K | 0.05% | 29 |
|
|
2021
Q3 | $75K | Hold |
8,500
| – | – | 0.05% | 32 |
|
|
2021
Q2 | $86K | Sell |
8,500
-5,519
| -39% | -$55.8K | 0.05% | 29 |
|
|
2021
Q1 | $93K | Sell |
14,019
-271
| -2% | -$1.8K | 0.06% | 25 |
|
|
2020
Q4 | $123K | Sell |
14,290
-1,410
| -9% | -$12.1K | 0.08% | 24 |
|
|
2020
Q3 | $114K | Buy |
15,700
+2,743
| +21% | +$19.9K | 0.09% | 28 |
|
|
2020
Q2 | $109K | Hold |
12,957
| – | – | 0.08% | 29 |
|
|
2020
Q1 | $82K | Buy |
12,957
+7,049
| +119% | +$44.6K | 0.07% | 30 |
|
|
2019
Q4 | $59K | Buy |
+5,908
| New | +$59K | 0.03% | 34 |
|